drugset / Trial / NCT00039182
Erlotinib in Treating Patients With Malignant Mesothelioma of the Lung
NaSingle-groupOpen-labelTreatment
Summary
Erlotinib may interfere with the growth of tumor cells and slow the growth of the tumor. This phase II trial is studying how well erlotinib works in treating patients with malignant mesothelioma of the lung
Timeline
- Start
- 2002-05
- Primary completion
- 2007-06
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Erlotinib | Small molecule | — | Oral |